These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16733563)

  • 1. Expression of soluble recombinant TGF-beta type II receptor fused with the Fc portion of human IgG1 (sTbetaRII-Fc) in NS0 cells.
    Kwiatkowska EP; Kazimierczak U; Mackiewicz A; Kowalczyk DW
    Acta Biochim Pol; 2006; 53(2):361-9. PubMed ID: 16733563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of recombinant human soluble type II transforming growth factor-beta receptor in Pichia pastoris and Escherichia coli: two powerful systems to express a potent inhibitor of transforming growth factor-beta.
    Glansbeek HL; van Beuningen HM; Vitters EL; van der Kraan PM; van den Berg WB
    Protein Expr Purif; 1998 Mar; 12(2):201-7. PubMed ID: 9518461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of a fusion protein of the extracellular domain of BR3 with the Fc fragment of human IgG1 (sBR3-Fc) in Pichia pastoris as an antagonist for BLyS.
    Cao P; Zhang S; Fang Z; Huang H; Bai P; Zhang Q; Luo C
    Appl Microbiol Biotechnol; 2008 Feb; 78(2):275-82. PubMed ID: 18189138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a role of transforming growth factor (TGF)-beta1 in the induction of postglomerular albuminuria in diabetic nephropathy: amelioration by soluble TGF-beta type II receptor.
    Russo LM; del Re E; Brown D; Lin HY
    Diabetes; 2007 Feb; 56(2):380-8. PubMed ID: 17259382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble transforming growth factor beta type II receptor attenuates TGF-beta1 activity in human colorectal cancer LoVo cells.
    Zhou R; Xiong B; Song H; Liu S; Wang X
    Oncol Rep; 2008 Dec; 20(6):1449-56. PubMed ID: 19020727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Horse cytokine/IgG fusion proteins--mammalian expression of biologically active cytokines and a system to verify antibody specificity to equine cytokines.
    Wagner B; Robeson J; McCracken M; Wattrang E; Antczak DF
    Vet Immunol Immunopathol; 2005 May; 105(1-2):1-14. PubMed ID: 15797470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of human transforming growth factor-beta1 using a recombinant CHO cell expression system.
    Zou Z; Sun PD
    Protein Expr Purif; 2004 Oct; 37(2):265-72. PubMed ID: 15358346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cloning, expression and bio-activity assay of chimeric fusion protein sTNFRII-IgG Fc].
    Xu CX; Yao LH; Zu D; Chen AJ; Huang GJ; Zhang ZQ
    Sheng Wu Gong Cheng Xue Bao; 2002 Jan; 18(2):178-81. PubMed ID: 12148279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chimeric extracellular domain type II transforming growth factor (TGF)-beta receptor fused to the Fc region of human immunoglobulin as a TGF-beta antagonist.
    Komesli S; Vivien D; Dutartre P
    Eur J Biochem; 1998 Jun; 254(3):505-13. PubMed ID: 9688260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of recombinant extracellular domain of the type II transforming growth factor-beta receptor: utilization in a modified enzyme-linked immunoabsorbent assay to screen TGF-beta agonists and antagonists.
    Fahey MS; Dawbarn D; Allen SJ; Paterson IC; Prime SS
    Anal Biochem; 2001 Mar; 290(2):272-6. PubMed ID: 11237329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoembryonic antigen-immunoglobulin Fc fusion protein (CEA-Fc) for identification and activation of anti-CEA immunoglobulin-T-cell receptor-modified T cells, representative of a new class of Ig fusion proteins.
    Ma Q; DeMarte L; Wang Y; Stanners CP; Junghans RP
    Cancer Gene Ther; 2004 Apr; 11(4):297-306. PubMed ID: 15002034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and ligand binding assays of soluble cytokine receptor-immunoglobulin fusion proteins.
    Brown SJ; Becherer KA; Blumeyer K; Kautzer C; Axelrod F; Le H; McConnell SJ; Whalley A; Spinella DG
    Protein Expr Purif; 1998 Oct; 14(1):120-4. PubMed ID: 9758759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of divalent H-2Kd/IgG2aFc fusion protein to murine macrophage via Fc-FcR interaction.
    Xiao W; Chen X; Lin Zhou ; Lu S; Liang Z; Wu X
    Cell Mol Immunol; 2007 Apr; 4(2):147-51. PubMed ID: 17571461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient production of human Fas receptor extracellular domain-human IgG1 heavy chain Fc domain fusion protein using baculovirus/silkworm expression system.
    Muraki M; Honda S
    Protein Expr Purif; 2010 Oct; 73(2):209-16. PubMed ID: 20576530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An efficient method for expression in Escherichia coli and purification of the extracellular ligand binding domain of the human TGFbeta type II receptor.
    Gasparian ME; Elistratov PA; Yakimov SA; Dolgikh DA; Kirpichnikov MP
    J Biotechnol; 2010 Jul; 148(2-3):113-8. PubMed ID: 20451568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-mediated blockade of integrin alpha v beta 6 inhibits tumor progression in vivo by a transforming growth factor-beta-regulated mechanism.
    Van Aarsen LA; Leone DR; Ho S; Dolinski BM; McCoon PE; LePage DJ; Kelly R; Heaney G; Rayhorn P; Reid C; Simon KJ; Horan GS; Tao N; Gardner HA; Skelly MM; Gown AM; Thomas GJ; Weinreb PH; Fawell SE; Violette SM
    Cancer Res; 2008 Jan; 68(2):561-70. PubMed ID: 18199553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of functional transforming growth factor (TGF)-beta type II receptor results in insensitivity to TGF-beta1-mediated apoptosis and Epstein-Barr virus reactivation.
    Fukuda M; Kurosaki H; Sairenji T
    J Med Virol; 2006 Nov; 78(11):1456-64. PubMed ID: 16998876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell surface expression of a human IgG Fc chimera activates macrophages through Fc receptors.
    Stabila PF; Wong SC; Kaplan FA; Tao W
    Nat Biotechnol; 1998 Dec; 16(13):1357-60. PubMed ID: 9853619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of TPO mimetic peptide chimeric proteins with human IgG1 Fc fragments and their biological characters].
    Li YX; Li C; Tao KH; Jia XH; Cheng DS; Huang PT
    Sheng Wu Gong Cheng Xue Bao; 2002 Jul; 18(4):424-30. PubMed ID: 12385237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells.
    Falco M; Marcenaro E; Romeo E; Bellora F; Marras D; Vély F; Ferracci G; Moretta L; Moretta A; Bottino C
    Eur J Immunol; 2004 Jun; 34(6):1663-72. PubMed ID: 15162436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.